These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7160838)

  • 21. Distribution of vasopressin and oxytocin in rat brain.
    Hashimoto H; Fukui K; Noto T; Nakajima T; Kato N
    Endocrinol Jpn; 1985 Feb; 32(1):89-97. PubMed ID: 4017977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic peptide content and nuclear estrogen binding of magnocellular neurons in the hypothalamus of Long-Evans and Brattleboro rats.
    Rhodes CH; Morrell JI; Pfaff DW
    Ann N Y Acad Sci; 1982; 394():767-75. PubMed ID: 6960796
    [No Abstract]   [Full Text] [Related]  

  • 23. The study of neurohypophyseal hormone receptors by ligand binding.
    Wheatley M; Howl J; Davies AR; Parslow RA
    Biochem Soc Trans; 1994 Feb; 22(1):113-8. PubMed ID: 8206202
    [No Abstract]   [Full Text] [Related]  

  • 24. Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.
    Schriefer JA
    Neuroendocrinology; 1991 Sep; 54(3):185-91. PubMed ID: 1682832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical localization of the vertebrate cyclic nonapeptide neurohypophyseal hormones and neurophysins.
    Dierickx K
    Int Rev Cytol; 1980; 62():119-85. PubMed ID: 6988359
    [No Abstract]   [Full Text] [Related]  

  • 26. Time course of appearance and release of [35S]cysteine labelled neurophysins and peptides in the neurohypophysis.
    Russell JT; Brownstein MJ; Gainer H
    Brain Res; 1981 Feb; 205(2):299-311. PubMed ID: 6162515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro.
    Bridges TE; Hillhouse EW; Jones MT
    J Physiol; 1976 Sep; 260(3):647-66. PubMed ID: 988183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure, processing and evolution of the neurohypophysial hormone-neurophysin precursors.
    Acher R; Chauvet J
    Biochimie; 1988 Sep; 70(9):1197-207. PubMed ID: 3147712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior.
    Laczi F; Gaffori O; de Kloet ER; de Wied D
    Brain Res; 1983 Feb; 260(2):342-6. PubMed ID: 6831206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin: site of behavioral action and role in human mental performance.
    Van Wimersma Greidanus TB; Veldhuis HD
    Peptides; 1985; 6 Suppl 2():177-80. PubMed ID: 4080615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
    Kovács GL; De Wied D
    Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of neurohypophyseal peptides on the formation of active avoidance conditioned reflex behavior.
    Ibragimov RSh
    Neurosci Behav Physiol; 1990; 20(3):189-93. PubMed ID: 1977096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL; Veldhuis HD; Versteeg DH; De Wied D
    Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 13C nuclear magnetic resonance studies of the interactions of bovine neurophysins with (1-hemi-(1-13C)cystine)oxytocin and (1-hemi-(1-13C)cystine,8-arginine)vasopressin.
    Blumenstein M; Hruby VJ; Yamamoto D; Yang Y
    FEBS Lett; 1977 Sep; 81(2):347-50. PubMed ID: 923806
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ultrastructural localization of neurohypophyseal hormones and their carrier proteins by the "triple bridge" immunoenzymatic technique].
    Dreyfuss F; Burlet A
    C R Seances Soc Biol Fil; 1977; 171(4):914-8. PubMed ID: 145302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The posterior pituitary gland.
    Chard T
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):89-106. PubMed ID: 1091379
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of prostaglandin E2 and D2 on the release of vasopressin and oxytocin.
    Hashimoto H; Noto T; Nakajima T
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):9-14. PubMed ID: 2740415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The carboxy terminus of the precursor to vasopressin and neurophysin: immunocytochemistry in rat brain.
    Watson SJ; Seidah NG; Chrétien M
    Science; 1982 Aug; 217(4562):853-5. PubMed ID: 6125034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of response in the release of oxytocin and vasopressin from isolated neurohypophyses to dopamine, met-enkephalin and leu-enkephalin.
    Pitzel L; König A
    Exp Brain Res; 1984; 56(2):221-6. PubMed ID: 6090193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.